Cargando…

A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia

BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss in adults, which is generally progressive in the absence of treatment. As a head full of healthy hair adds to the cosmetic appeal of the individual, the consequences of AGA are predominantly psychological. Currently, topica...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Muriki K., Inamadar, Arun C., Palit, Aparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371730/
https://www.ncbi.nlm.nih.gov/pubmed/30886475
http://dx.doi.org/10.4103/JCAS.JCAS_130_17
_version_ 1783394621369352192
author Kumar, Muriki K.
Inamadar, Arun C.
Palit, Aparna
author_facet Kumar, Muriki K.
Inamadar, Arun C.
Palit, Aparna
author_sort Kumar, Muriki K.
collection PubMed
description BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss in adults, which is generally progressive in the absence of treatment. As a head full of healthy hair adds to the cosmetic appeal of the individual, the consequences of AGA are predominantly psychological. Currently, topical minoxidil is the first-line treatment for AGA. Many adjuvant treatment modalities have been used synergistically with minoxidil. Microneedling is one among such adjuvant treatments, which works by various mechanisms to stimulate the dermal papillary cells that play a key role in hair growth. AIM: To compare the efficacy of microneedling along with topical minoxidil and topical minoxidil alone in the treatment of AGA in men. MATERIALS AND METHODS: Sixty-eight men with Norwood–Hamilton grade III and IV AGA were recruited for the study. After randomization, one group was treated with weekly microneedling and twice daily application of 5% minoxidil solution and the other group was treated with twice daily application of 5% minoxidil solution alone. Global photographs were taken at baseline (pretreatment) and at end of the study duration. Trichoscopic images were taken from a targeted fixed area before treatment (baseline) and at end of the therapy from where hair count was also carried out. The two primary efficacy parameters were assessed: increase in the hair count from that of the baseline and patient self-assessment of hair growth at the end of the study. RESULTS: The mean increase in hair count in the targeted area of one square inch at the end of the treatment was significantly greater for the combination treatment group (12.52/inch(2)) compared to that for the minoxidil alone group (1.89/inch(2)). Four patients in the “microneedling plus topical minoxidil” group reported a 50% improvement versus none in the “minoxidil alone” group. CONCLUSION: Our study showed that the combination of microneedling and topical minoxidil treatment was superior compared to topical minoxidil alone with regard to increase in the hair count and patient satisfaction, although the response achieved was not cosmetically significant.
format Online
Article
Text
id pubmed-6371730
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63717302019-03-18 A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia Kumar, Muriki K. Inamadar, Arun C. Palit, Aparna J Cutan Aesthet Surg Original Article BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss in adults, which is generally progressive in the absence of treatment. As a head full of healthy hair adds to the cosmetic appeal of the individual, the consequences of AGA are predominantly psychological. Currently, topical minoxidil is the first-line treatment for AGA. Many adjuvant treatment modalities have been used synergistically with minoxidil. Microneedling is one among such adjuvant treatments, which works by various mechanisms to stimulate the dermal papillary cells that play a key role in hair growth. AIM: To compare the efficacy of microneedling along with topical minoxidil and topical minoxidil alone in the treatment of AGA in men. MATERIALS AND METHODS: Sixty-eight men with Norwood–Hamilton grade III and IV AGA were recruited for the study. After randomization, one group was treated with weekly microneedling and twice daily application of 5% minoxidil solution and the other group was treated with twice daily application of 5% minoxidil solution alone. Global photographs were taken at baseline (pretreatment) and at end of the study duration. Trichoscopic images were taken from a targeted fixed area before treatment (baseline) and at end of the therapy from where hair count was also carried out. The two primary efficacy parameters were assessed: increase in the hair count from that of the baseline and patient self-assessment of hair growth at the end of the study. RESULTS: The mean increase in hair count in the targeted area of one square inch at the end of the treatment was significantly greater for the combination treatment group (12.52/inch(2)) compared to that for the minoxidil alone group (1.89/inch(2)). Four patients in the “microneedling plus topical minoxidil” group reported a 50% improvement versus none in the “minoxidil alone” group. CONCLUSION: Our study showed that the combination of microneedling and topical minoxidil treatment was superior compared to topical minoxidil alone with regard to increase in the hair count and patient satisfaction, although the response achieved was not cosmetically significant. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6371730/ /pubmed/30886475 http://dx.doi.org/10.4103/JCAS.JCAS_130_17 Text en Copyright: © 2019 Journal of Cutaneous and Aesthetic Surgery http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kumar, Muriki K.
Inamadar, Arun C.
Palit, Aparna
A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
title A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
title_full A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
title_fullStr A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
title_full_unstemmed A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
title_short A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
title_sort randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371730/
https://www.ncbi.nlm.nih.gov/pubmed/30886475
http://dx.doi.org/10.4103/JCAS.JCAS_130_17
work_keys_str_mv AT kumarmurikik arandomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia
AT inamadararunc arandomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia
AT palitaparna arandomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia
AT kumarmurikik randomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia
AT inamadararunc randomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia
AT palitaparna randomizedcontrolledsingleobserverblindedstudytodeterminetheefficacyoftopicalminoxidilplusmicroneedlingversustopicalminoxidilaloneinthetreatmentofandrogeneticalopecia